Status: current, Defined. Date: 31-Mar 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1834031000168119 | asfotase alfa 12 mg / 0.3 mL injection, 1 x 0.3 mL vial (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1834041000168111 | asfotase alfa 12 mg/0.3 mL injection, 0.3 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| asfotase alfa 12 mg/0.3 mL injection, 0.3 mL vial | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| asfotase alfa 12 mg/0.3 mL injection, 0.3 mL vial | has MPUU | asfotase alfa 12 mg/0.3 mL injection, vial | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Strensiq 12 mg/0.3 mL injection, 0.3 mL vial | Is a | True | asfotase alfa 12 mg/0.3 mL injection, 0.3 mL vial | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR